Antibodies Inhibiting the Type III Secretion System of Gram-Negative Pathogenic Bacteria
Pathogenic bacteria are a global health threat, with over 2 million infections caused by Gram-negative bacteria every year in the United States. This problem is exacerbated by the increase in resistance to common antibiotics that are routinely used to treat these infections, creating an urgent need...
Main Authors: | Julia A. Hotinger, Aaron E. May |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4468/9/3/35 |
Similar Items
-
Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components
by: Julia A. Hotinger, et al.
Published: (2021-02-01) -
Animal Models of Type III Secretion System-Mediated Pathogenesis
by: Julia A. Hotinger, et al.
Published: (2019-11-01) -
The Case against Antibiotics and for Anti-Virulence Therapeutics
by: Julia A. Hotinger, et al.
Published: (2021-09-01) -
Aurodox inhibits type III secretion in multiple Gram-negative pathogens
by: David R. Mark, et al.
Published: (2024-11-01) -
Delivery of Heterologous Proteins, Enzymes, and Antigens via the Bacterial Type III Secretion System
by: Heather A. Pendergrass, et al.
Published: (2020-05-01)